Teaching Your Body To Make Designer Antibodies
•InnovationHealthcareTeaching Your Body To Make Designer AntibodiesByWilliam A.
•Haseltine,Contributor.Forbes contributors publish independent expert analyses and insights.
•Haseltine, Ph.D., covers genomics and regenerative medicineFollow AuthorMay 13, 2026, 02:22pm EDT--:-- / --:--This voice experience is generated by AI.
هذا الخبر من Forbes. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
InnovationHealthcareTeaching Your Body To Make Designer AntibodiesByWilliam A. Haseltine,Contributor.Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicineFollow AuthorMay 13, 2026, 02:22pm EDT--:-- / --:--This voice experience is generated by AI. Learn more.This voice experience is generated by AI. Learn more.Teaching the body to manufacture “designer” antibodies from a tiny pool of edited stem cells could turn today’s short‑lived antibody infusions into a one‑time treatment that can be boosted for years.Image by MagnificAntibody drugs play a critical role in treating chronic infections, cancer and other persistent diseases, but their effects are short-lived. Patients require repeated infusions to maintain protection. A recent study introduces an alternative: rather than administering antibodies repeatedly, this method enables the body to produce its own supply for extended periods.The study, published in the journal Science, edited a small number of blood-forming cells in mice so that the immune cells those cells produce carry a blueprint for a chosen antibody. Once placed in the body, the edited cells grow into a living antibody factory that responds to a simple vaccine booster.Why Today’s Antibody Drugs Fall ShortAntibodies are proteins produced by the immune system to recognize and bind to harmful targets, including viruses and cancer cells. Pharmaceutical manufacturers produce these antibodies in controlled environments, purify them and administer them to patients. However, the body eliminates these antibodies within weeks, requiring patients to receive repeated doses to maintain therapeutic levels.The cost adds up fast. A single year of antibody treatment can run into tens of thousands of dollars. Some of the most useful antibodies, the rare kind that can block many different versions of a virus like HIV or the flu, are even harder to make and even harder to keep at the righ...المصدر: Forbes | Source: Forbes
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Forbes. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Forbes. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.


